Diagnostic Performance of the Cancer Ratio in Malignant Pleural Effusion in Combination with the Light’s Criteria
Acta Médica Portuguesa · 2026
DOI: 10.20344/amp.24234 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Acta Médica Portuguesa, 2026. Verfasst von Maria João Cavaco und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center of Integrated Responsibility for Pneumology. Hospital de Torres Vedras. Unidade Local de Saúde do Oeste. Torres Vedras. Portugal. Hauptthemen laut MEDLINE: Pleural Effusion, Malignant, Adenosine Deaminase, L-Lactate Dehydrogenase. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The cancer ratio (CR), defined as serum lactate dehydrogenase to pleural fluid adenosine deaminase ratio (sLDH/pADA), has emerged as a diagnostic marker for malignant pleural effusion (MPE). However, previous studies have primarily compared MPE with exudative effusions, excluding transudates. The aim of this study was to determine the diagnostic accuracy of CR in differentiating MPE from benign pleural effusions (BPE), including both exudates and transudates. An observational analysis was conducted on patients with pleural effusion (PE) evaluated in a Portuguese center between January 2017 and August 2025. Diagnostic accuracy was assessed using receiver operating characteristic curves and area under the curve (AUC) analysis. Of the 423 PE evaluated, 154 (36.4%) were MPE and 269 (63.6%) were BPE, including 82 transudates, 159 true benign exudates (TBEPE) and 28 PE misclassified as exudates. Significantly higher CR levels were observed in MPE than in BPE (p < 0.001). When comparing MPE with TBEPE, a CR threshold of 20 yielded an AUC of 0.90, with 76.0% sensitivity and 93.1% specificity. The inclusion of misclassified exudative BPE and transudates reduced diagnostic accuracy (AUC 0.86/0.73, respectively). In conclusion, a CR > 20 is highly predictive of malignancy etiology. Accurate pre-classification according to the Light’s criteria is essential to preserve the diagnostic validity of this biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Integrated Responsibility for Pneumology. Hospital de Torres Vedras. Unidade Local de Saúde do Oeste. Torres Vedras. Portugal.
Zitieren
APA
Cavaco, M. J., Fontão Alves, S., Silva, C., Pimentel, S., Mateus, L., Rôlo Silvestre, C., Ferra, J., Duarte, D., Cardoso, C., Raimundo, P., & Falcão, T. (2026). Diagnostic Performance of the Cancer Ratio in Malignant Pleural Effusion in Combination with the Light’s Criteria. Acta Médica Portuguesa. https://doi.org/10.20344/amp.24234
Vancouver
Cavaco MJ, Fontão Alves S, Silva C, Pimentel S, Mateus L, Rôlo Silvestre C, et al. Diagnostic Performance of the Cancer Ratio in Malignant Pleural Effusion in Combination with the Light’s Criteria. Acta Médica Portuguesa. 2026. doi:10.20344/amp.24234
BibTeX
@article{Cavaco2026,
author = {Cavaco, Maria João and Fontão Alves, Sofia and Silva, Catarina and Pimentel, Sofia and Mateus, Luís and Rôlo Silvestre, Carina and Ferra, Joana and Duarte, Daniel and Cardoso, Carla and Raimundo, Paula and Falcão, Teresa},
title = {Diagnostic Performance of the Cancer Ratio in Malignant Pleural Effusion in Combination with the Light’s Criteria},
journal = {Acta Médica Portuguesa},
year = {2026},
doi = {10.20344/amp.24234}
}
EUVIMED